Status:
RECRUITING
Evaluation of the WARIFA App and Its Impact on Healthy Lifestyle
Lead Sponsor:
Instituto Universitario de Investigaciones Biomédicas y Sanitarias (iUIBS) de la Universidad de Las
Collaborating Sponsors:
Complejo Hospitalario Universitario Insular Materno Infantil
Conditions:
Lifestyle Intervention
Non Communicable Chronic Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to assess the effect of the WARIFA app on the adoption of healthy lifestyle behaviours related to Non-communicable diseases (NCDs), as well as in the management of Type 1 Dia...
Eligibility Criteria
Inclusion
- Common for both population groups:
- Adults over 18 years of age.
- Owners of a smartphone operating with Android and with internet access.
- Group 1: General population:
- Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease).
- Group 2: T1D:
- Treatment with multiple subcutaneous insulin injections or an insulin pump.
- Users of a continuous glucose monitor.
Exclusion
- Common for both groups:
- Pregnancy.
- Mobile device which is incompatible with the WARIFA app (E.g. Apple devices).
- Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian).
- Any reason which precludes follow-up, based on the researcher's criteria.
- Group 1: General population
- People with two or more NCDs.
Key Trial Info
Start Date :
February 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 29 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06918444
Start Date
February 24 2025
End Date
May 29 2025
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Universitario De Investigaciones Biomédicas y Sanitarias (IUIBS)
Las Palmas de Gran Canaria, Las Palmas, Spain, 35016